Evidence map›Paper›PMID 32244785›Full record

ArticleNutrients2020

Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy.

Soranobu Ninomiya, Nobuhiko Nakamura, Hiroshi Nakamura, Taku Mizutani, Yuto Kaneda, Kimihiro Yamaguchi, Takuro Matsumoto, Junichi Kitagawa, Nobuhiro Kanemura, Makoto Shiraki and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Metabolomic analyses of amyotrophic lateral sclerosis, muscle cramps, and TJ-68 treatment.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  4. Article
  5. Article
  6. Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.Journal of cachexia, sarcopenia and muscle · 2026
    Article
  7. Cancer cachexia: molecular basis and therapeutic advances.Signal transduction and targeted therapy · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Soranobu NinomiyaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0003-2583-0513
Nobuhiko NakamuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Hiroshi NakamuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Taku MizutaniFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Yuto KanedaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Kimihiro YamaguchiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Takuro MatsumotoFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Junichi KitagawaFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Nobuhiro KanemuraFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Makoto ShirakiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Takeshi HaraDepartment of Hematology, Matsunami General Hospital, Gifu 5016062, Japan.
Masahito ShimizuFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Hisashi TsurumiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Gifu University · JPMatsunami General Hospital · JP

Funding

undefined <span style="color:gray;font-size:10px;">undefined</span> JP18K15272
6 · The paper itself

Abstract

Sarcopenia is a poor prognosis factor in some cancer patients, but little is known about the mechanisms by which malignant tumors cause skeletal muscle atrophy. Tryptophan metabolism mediated by indoleamine 2,3-dioxygenase is one of the most important amino acid changes associated with cancer progression. Herein, we demonstrate the relationship between skeletal muscles and low levels of tryptophan. A positive correlation was observed between the volume of skeletal muscles and serum tryptophan levels in patients with diffuse large B-cell lymphoma. Low levels of tryptophan reduced C2C12 myoblast cell proliferation and differentiation. Fiber diameters in the tibialis anterior of C57BL/6 mice fed a tryptophan-deficient diet were smaller than those in mice fed a standard diet. Metabolomics analysis revealed that tryptophan-deficient diet downregulated glycolysis in the gastrocnemius and upregulated the concentrations of amino acids associated with the tricarboxylic acid cycle. The weights and muscle fiber diameters of mice fed the tryptophan-deficient diet recovered after switching to the standard diet. Our data showed a critical role for tryptophan in regulating skeletal muscle mass. Thus, the tryptophan metabolism pathway may be a promising target for preventing or treating skeletal muscle atrophies.

Indexed as

Amino AcidsAnimalsCell ProliferationCells, CulturedCitric Acid CycleDisease ProgressionGlycolysisIndoleamine-Pyrrole 2,3,-DioxygenaseMice, Inbred C57BLMuscular AtrophyMyoblastsNeoplasmsSarcopeniaTryptophanAmino AcidsIndoleamine-Pyrrole 2,3,-DioxygenaseTryptophancancerglycolysisindoleamine 2,3-dioxygenasesarcopeniatryptophan

Identifiers

PMID32244785
PMCPMC7230402
OpenAlexW3015177139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.